141 related articles for article (PubMed ID: 35907039)
21. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
[TBL] [Abstract][Full Text] [Related]
22. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
[TBL] [Abstract][Full Text] [Related]
23. NGS-based methylation profiling differentiates TCF3-HLF and TCF3-PBX1 positive B-cell acute lymphoblastic leukemia.
Kachroo P; Szymczak S; Heinsen FA; Forster M; Bethune J; Hemmrich-Stanisak G; Baker L; Schrappe M; Stanulla M; Franke A
Epigenomics; 2018 Feb; 10(2):133-147. PubMed ID: 29334255
[TBL] [Abstract][Full Text] [Related]
24. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in
Gutierrez-Camino A; Caron M; Richer C; Fuchs C; Illarregi U; Poncelet L; St-Onge P; Bataille AR; Tremblay-Dauphinais P; Lopez-Lopez E; Camos M; Ramirez-Orellana M; Astigarraga I; Lécuyer É; Bourque G; Martin-Guerrero I; Sinnett D
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338754
[TBL] [Abstract][Full Text] [Related]
25. Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in Children.
Lee SHR; Qian M; Yang W; Diedrich JD; Raetz E; Yang W; Dong Q; Devidas M; Pei D; Yeoh A; Cheng C; Pui CH; Evans WE; Mullighan CG; Hunger SP; Savic D; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2021 Jul; 113(7):933-937. PubMed ID: 32882024
[TBL] [Abstract][Full Text] [Related]
26. Very late relapse cases of TCF3-ZNF384-positive acute lymphoblastic leukemia.
Nishimura A; Hasegawa D; Hirabayashi S; Kanabuchi S; Yamamoto K; Aiga S; Nishitani M; Hosoya Y; Noguchi Y; Ohki K; Kiyokawa N; Mori S; Manabe A
Pediatr Blood Cancer; 2019 Nov; 66(11):e27891. PubMed ID: 31347769
[No Abstract] [Full Text] [Related]
27. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
[TBL] [Abstract][Full Text] [Related]
28. [Identification of TCF3-ZNF384 fusion by transcriptome sequencing in B cell acute lymphoblastic leukemia and its laboratory and clinical characteristics].
Wu Q; Wang F; Yang J; Chen X; Ma X; Cao P; Zhang Y; Nie D; Chen J; Zhou X; Fang J; Liu M; Zhang M; Wu P; Wang T; Liu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Apr; 38(4):351-354. PubMed ID: 33834463
[TBL] [Abstract][Full Text] [Related]
29. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
Hunger SP; Ohyashiki K; Toyama K; Cleary ML
Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
[TBL] [Abstract][Full Text] [Related]
30. Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1.
Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Mori T; Yoshida M; Yoshida K; Kohri M; Ishihara T; Yasue S; Imamura T; Endo M; Miyamoto S; Ohki K; Sanada M; Kiyokawa N; Ogawa S; Yoshioka T; Hata K; Takagi M; Kato M
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1559. PubMed ID: 34553842
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature.
Sarashina T; Iwabuchi H; Miyagawa N; Sekimizu M; Yokosuka T; Fukuda K; Hamanoue S; Iwasaki F; Goto S; Shiomi M; Imai C; Goto H
Int J Hematol; 2016 Jul; 104(1):139-43. PubMed ID: 27084248
[TBL] [Abstract][Full Text] [Related]
33. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
[TBL] [Abstract][Full Text] [Related]
34. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
Duque-Afonso J; Smith KS; Cleary ML
PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248
[TBL] [Abstract][Full Text] [Related]
35. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
Hunger SP; Brown R; Cleary ML
Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
[TBL] [Abstract][Full Text] [Related]
36. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
[TBL] [Abstract][Full Text] [Related]
37. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X
Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861
[TBL] [Abstract][Full Text] [Related]
38. Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia.
Jędraszek K; Malczewska M; Parysek-Wójcik K; Lejman M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328487
[TBL] [Abstract][Full Text] [Related]
39. Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
[TBL] [Abstract][Full Text] [Related]
40. Rare
Miyamoto S; Urayama KY; Arakawa Y; Koh K; Yuza Y; Hasegawa D; Taneyama Y; Noguchi Y; Yanagimachi M; Inukai T; Ota S; Takahashi H; Keino D; Toyama D; Takita J; Tomizawa D; Morio T; Koike K; Moriwaki K; Sato Y; Fujimura J; Morita D; Sekinaka Y; Nakamura K; Sakashita K; Goto H; Manabe A; Takagi M
Pediatr Hematol Oncol; 2024; 41(1):81-87. PubMed ID: 37129918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]